Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps

Area of Science:

• Medical Ethics
• Pharmacology
• Public Health Emergencies

Background:

• The COVID-19 pandemic spurred interest in drug repurposing (drug repositioning) for rapid treatment development.
• However, limited research has explored the broader social and ethical implications of drug repurposing during emergencies.
• Fairness in resource distribution emerges as a critical ethical concern in emergency drug repurposing.

Purpose of the Study:

• To examine drug repurposing in emergency situations, with a specific focus on fairness.
• To analyze ethical issues related to drug repurposing in emergency contexts, using Japanese case studies.
• To identify key ethical challenges including evidence levels, research integrity, and patient consent.

Main Methods:

• Analysis of Japanese case studies on drug repurposing during emergencies.
• Examination of ethical considerations pertinent to emergency drug repositioning.
• Review of ethical issues such as maintaining evidence standards and patient consent.

Main Results:

• Drug repurposing in emergencies raises significant ethical questions regarding fair resource allocation.
• Maintaining high standards of evidence and research ethics is crucial.
• Ensuring voluntary consent from patients in original indications presents challenges.

Conclusions:

• Ethical drug repurposing in emergencies necessitates the rapid generation of scientifically and ethically sound evidence.
• Transparency regarding resource availability is essential for fair distribution.
• Addressing these ethical dimensions is vital for responsible emergency drug repositioning.